Clonazepam has long been recognized as one of the better-proven treatment options for extended-term neurological and psychiatric care as a result of its precision system of action, very long 50 percent-life and verified scientific dependability. Its capacity to selectively bind to GABA-A receptors and stabilize hyperactive neural pathways makes it